Ensysce Biosciences, Inc. (ENSC, ENSCW) (CIK 0001716947) (ENSC)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Apr. 14, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 14, 2026 | CORRESP | Neutral/Informational | Moderate | Ensysce Biosciences, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, originally filed on April 9, 2026. They … | Read Filing EDGAR |
| Apr. 13, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated April 13, 2026, informs Ensysce Biosciences, Inc. that their registration statement on Form S-3 filed on April 9, 2026, will not be reviewed by the SE… | Read Filing EDGAR |
| Dec. 9, 2025 | CORRESP | Neutral/Informational | Moderate | Ensysce Biosciences, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, originally filed on December 2, 2025. Th… | Read Filing EDGAR |